Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofirmev for intrapartum maternal fever and fetal tachycardia
NCT02625454Phase 2Unknown
- Sponsor
- Richmond University Medical Center
- Start
- Dec 2016
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetaminophen in fever and tachycardia (2 arms), sponsored by Richmond University Medical Center. Primary endpoint: Change in Maternal Body Temperature. Status: unknown.
02
Drugs
acetaminophen
03
Conditions
fevertachycardia
Beyond the preview
Go deeper on NCT02625454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02625454.